| Xiao Yun Wang, MD | |
|
601 E 15th St, Department Of Pathology, Austin, TX 78701-1930 | |
| (512) 324-7516 | |
| (512) 324-7536 |
| Full Name | Xiao Yun Wang |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 22 Years |
| Location | 601 E 15th St, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962628842 | NPI | - | NPPES |
| 195386101 | Medicaid | TX | |
| 8BL181 | Other | TX | BCBSTX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 32299 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St David's South Austin Medical Center | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Pathology Associates | 7012902539 | 24 |
News Archive
PROLOR Biotech, Inc., announced that the company will present data today on its long-acting clotting factors for the treatment of hemophilia at the World Federation of Hemophilia (WFH) World Congress.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
It's official, everyone is getting ready for the Christmas Party Season. Research published this week from British Lion Eggs stated that 6 out of 10 women will be slimming down to fit into those LBDs from now until December in order to look their very shimmering best!
An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans.
› Verified 9 days ago
| Entity Name | Austin Pathology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538172028 PECOS PAC ID: 7012902539 Enrollment ID: O20070207000471 |
News Archive
PROLOR Biotech, Inc., announced that the company will present data today on its long-acting clotting factors for the treatment of hemophilia at the World Federation of Hemophilia (WFH) World Congress.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
It's official, everyone is getting ready for the Christmas Party Season. Research published this week from British Lion Eggs stated that 6 out of 10 women will be slimming down to fit into those LBDs from now until December in order to look their very shimmering best!
An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Xiao Yun Wang, MD Po Box 164106, Austin, TX 78716-4106 Ph: (512) 324-7516 | Xiao Yun Wang, MD 601 E 15th St, Department Of Pathology, Austin, TX 78701-1930 Ph: (512) 324-7516 |
News Archive
PROLOR Biotech, Inc., announced that the company will present data today on its long-acting clotting factors for the treatment of hemophilia at the World Federation of Hemophilia (WFH) World Congress.
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
It's official, everyone is getting ready for the Christmas Party Season. Research published this week from British Lion Eggs stated that 6 out of 10 women will be slimming down to fit into those LBDs from now until December in order to look their very shimmering best!
An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans.
› Verified 9 days ago
Dr. Joseph Howard Willman, MD Pathology Medicare: Medicare Enrolled Practice Location: 3445 Executive Center Dr, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Dr. Robert Domingo, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 12357 A Riata Trace Pkwy, Bldg 5, Ste 100, Thyroid Cytopathology Partners, Austin, TX 78727 Phone: 512-814-0298 Fax: 512-597-2713 | |
Christine Renee Burgess, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Drive, Ste 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Dr. Grace Nightingale Cortez Jackson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Drive, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Jared Dale Barker, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Dr., Ste 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Vilmos A Thomazy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 12221 N Mopac Expressway, Namc Department Of Pathology, Austin, TX 78756 Phone: 512-901-1206 Fax: 512-901-1299 | |
Dr. Paul Brooks Gaudin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Dr, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 |